Cargando…

Therapeutic Strategies and Chemoprevention of Atherosclerosis: What Do We Know and Where Do We Go?

Despite progress in understanding the pathogenesis of atherosclerosis, the development of effective therapeutic strategies is a challenging task that requires more research to attain its full potential. This review discusses current pharmacotherapy in atherosclerosis and explores the potential of so...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aprotosoaie, Ana Clara, Costache, Alexandru-Dan, Costache, Irina-Iuliana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025701/ https://www.ncbi.nlm.nih.gov/pubmed/35456556 http://dx.doi.org/10.3390/pharmaceutics14040722

Ejemplares similares

Maternal sleep position: what do we know where do we go?
por: O’Brien, Louise M, et al.
Publicado: (2015)

Coffee and digestive cancers—what do we know, and where do we go?
por: Loftfield, Erikka, et al.
Publicado: (2020)

Resistance in tuberculosis: what do we know and where can we go?
por: Green, Keith D., et al.
Publicado: (2013)

The lingering dilemma of arterial pressure in CKD: what do we know, where do we go?
por: Agarwal, Rajiv, et al.
Publicado: (2011)

Minimally Invasive Glaucoma Surgery: What Do We Know? Where Should We Go?
por: Xin, Chen, et al.
Publicado: (2020)

Intraoperative Brain Mapping in Multilingual Patients: What Do We Know and Where Are We Going?
por: Martín-Fernández, Jesús, et al.
Publicado: (2022)

Aquatic Exercise Programs for Children and Adolescents with Cerebral Palsy: What Do We Know and Where Do We Go?
por: Gorter, J. W., et al.
Publicado: (2011)

Mechanisms of Maggot-Induced Wound Healing: What Do We Know, and Where Do We Go from Here?
por: Sherman, Ronald A.
Publicado: (2014)

Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

How to Prevent Injuries in Alpine Ski Racing: What Do We Know and Where Do We Go from Here?
por: Spörri, Jörg, et al.
Publicado: (2016)

Validating Cell Surface Proteases as Drug Targets for Cancer Therapy: What Do We Know, and Where Do We Go?
por: Verhulst, Emile, et al.
Publicado: (2022)

Chronic Kidney Disease of Unknown Etiology in India: What Do We Know and Where We Need to Go
por: John, Oommen, et al.
Publicado: (2021)

E-Leadership and Teleworking in Times of COVID-19 and Beyond: What We Know and Where Do We Go
por: Contreras, Francoise, et al.
Publicado: (2020)

What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)

Placebo analgesia effects across central nervous system diseases: what do we know and where do we need to go?
por: Matthiesen, Susan Tomczak, et al.
Publicado: (2019)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

Plant root plasticity during drought and recovery: What do we know and where to go?
por: Zheng, Congcong, et al.
Publicado: (2023)

Spinal cord injury and neurogenic lower urinary tract dysfunction: what do we know and where are we going?
por: Dodd, William, et al.
Publicado: (2022)

ColVI myopathies: where do we stand, where do we go?
por: Allamand, Valérie, et al.
Publicado: (2011)

Nanoparticles in the environment: where do we come from, where do we go to?
por: Bundschuh, Mirco, et al.
Publicado: (2018)

EBCOG: European Board and College of Obstetrics and Gynaecology: Who are we? What do we do? Where do we go?
por: Hornnes, P., et al.
Publicado: (2010)

Pharmacological approach to iatrogenic bleeding during bronchoscopy: what do we know so far and where do we go from here?
por: Alfaiate, Ana, et al.
Publicado: (2023)

International collaboration and covid-19: what are we doing and where are we going?
por: Bump, Jesse B, et al.
Publicado: (2021)

Dermal Matrices: Do We Always Know What Is Going On?
por: Agostinho, Mariana, et al.
Publicado: (2022)

Neuropsychiatry: Where Are We And Where Do We Go From Here?
por: Sachdev, Perminder S., et al.
Publicado: (2013)

Addictive behaviors: where do we stand, and where are we going?
por: Thibaut, Florence, et al.
Publicado: (2017)

Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)

The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next?
por: Mitra, Anita, et al.
Publicado: (2016)

Pregnant adolescents living with HIV: what we know, what we need to know, where we need to go
por: Callahan, Tegan, et al.
Publicado: (2017)

Implantable Cardioverter Defibrillator in Primary and Secondary Prevention of SCD—What We Still Don′t Know
por: Ursaru, Andreea Maria, et al.
Publicado: (2022)

Home sharing in marketing and tourism at a tipping point: What do we know, how do we know, and where should we be heading?
por: Lim, Weng Marc, et al.
Publicado: (2021)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

Pharmacokinetic Interactions between Cardiovascular Medicines and Plant Products
por: Costache, Irina-Iuliana, et al.
Publicado: (2019)

Hearing Loss and Cognition: What We Know and Where We Need to Go
por: Powell, Danielle S., et al.
Publicado: (2022)

Psychopharmacology Today: Where are We and Where Do We Go From Here?
por: Schwartz, Thomas L.
Publicado: (2010)

Health Psychology: Where Are We And Where Do We Go From Here?
por: Kaplan, Robert M.
Publicado: (2009)

Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?
por: Ottenhoff, Tom H. M., et al.
Publicado: (2012)

Precision medicine in COPD: where are we and where do we need to go?
por: Sidhaye, Venkataramana K., et al.
Publicado: (2018)

Biomarkers for Alzheimer’s Disease: Where Do We Stand and Where Are We Going?
por: Villa, Chiara
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ml2osdt8mhl8kr2h3sbt6pccmo